Hubert Czerniak - NIACYNA cz. 1 z 4 / Witamina B3 bez tajemnic / Niesamowite i skrywane właściwości

The speaker contrasts the effects of niacin forms. Immediate-release nicotinic acid is effective and safe for the liver, while slow-release niacin, designed to avoid flush, concentrates in the liver and becomes toxic. He cites McKenney's 30-week trial where 0/23 patients on immediate-release had liver issues vs 52% on SR. He also mentions the UC Irvine experiment that illuminated the mechanism. He emphasizes that pharmaceutical companies created patented forms like inositol hexanicotinate to profit, but they are less effective or dangerous.

The speaker presents Hoffer's work showing 90% recovery rate in schizophrenics treated with niacin, contrasted with 0% using conventional neuroleptics. He describes schizophrenics as highly perceptive individuals whose brains break down under niacin deficiency, leading to disordered reality interpretation. Standard drugs sedate them into a zombie state, while niacin addresses the root biochemical cause. This is part of the orthomolecular paradigm that sees mental illness as a biochemical individuality issue. The speaker underscores that this knowledge is ignored because niacin cannot be patented.

The speaker draws a direct line from mitochondrial dysfunction to cancer, explaining that transferring mitochondria from cancer cells induces cancer in normal cells. He argues that supplying optimal nutrients, especially niacin, allows the body's detox pathways (e.g., cytochrome P450) to manage xenobiotics and maintain mitochondrial integrity. This positions high-dose niacin as a general anti-cancer prophylactic, though clinical translation is still experimental. The 90% slowing of cancer growth in niacin-treated cells underscores the potential magnitude of the effect.

The speaker describes finding the book 'Niacyna w leczeniu' (Niacin in Treatment) by Abram Hoffer, Harold Foster, and Andrew Saul. He explains that the truth about niacin is hidden because it can't be patented, and mainstream medicine focuses on patentable drugs. He contrasts the public's ignorance with the potential of orthomolecular therapy that uses high doses of vitamins and minerals. He notes that even Linus Pauling, a Nobel laureate, was ridiculed for promoting vitamin C, yet his advocacy coincided with a decline in cardiovascular mortality. The speaker adopts the view that many psychiatric and metabolic disorders have a biochemical basis that niacin can address.

The speaker cites studies comparing forms: on liver cells, nicotinic acid blocked HDL reuptake, improving lipid profile. Niacinamide had no such effect and caused nausea in gram doses. Inositol hexanicotinate (6 niacin molecules on inositol) lowered cholesterol but less effectively and is patented, making it expensive and prescription-only. Slow-release niacin was investigated; Henkin et al. found 8/15 patients developed liver toxicity, whereas 0/67 on immediate-release did. McKenney's group gave 500–3000 mg/day for 30 weeks: 0/23 immediate-release had liver issues versus 12/23 (52%) on slow-release. The speaker emphasizes the need to avoid slow-release niacin.

The speaker points out that MEDLINE, funded by taxpayers, contains no papers from orthomolecular psychiatry despite the existence of numerous published articles. He claims that the drug industry suppresses this information because niacin cannot be patented. He references Linus Pauling, who noted that about 2.5% of the population has unique nutritional needs and may be geniuses, including schizophrenics. The speaker criticizes conventional psychiatry for drugging schizophrenics into a zombie state instead of correcting underlying biochemical deficiencies. He stresses that niacin's broad effects are dismissed when attributed to one vitamin, whereas a multi-purpose drug is celebrated.

The speaker explains that schizophrenics have a higher biochemical demand for niacin; when deficient, they experience hallucinations and interpret reality abnormally. In contrast to the standard pharmacological approach that renders patients catatonic and socially lost, high-dose niacin addresses the root cause. He describes schizophrenics as 'iPhone compared to old Nokia'— their brains are highly organized and capable of seeing connections others miss. Physically, they tend to age gracefully and are more eloquent. The speaker asserts that conventional medicine offers 0% cure, whereas with niacin, around 90% can recover. This aligns with the orthomolecular view that mental illness often has a nutritional/biochemical origin.

The speaker uses the analogy of a frozen laptop requiring battery removal for reset. When mitochondria, the cell's powerhouse with its own DNA (inherited maternally), face excessive toxins and insufficient nutrients, they falter and initiate a mitotic division to reset. However, if the toxic environment persists, this leads to rapid, undifferentiated cell division – cancer. He cites research showing that transferring mitochondria from a cancer cell into a healthy cell causes cancer, proving the mitochondrial origin. He then notes that pre-treating cells with high niacin made them 90% more resistant to carcinogens, slowing cancer development drastically. This suggests niacin supports mitochondrial resilience, preventing the carcinogenic switch.